BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ai L, Chen J, Yan H, He Q, Luo P, Xu Z, Yang X. Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy. Drug Des Devel Ther 2020;14:3625-49. [PMID: 32982171 DOI: 10.2147/DDDT.S267433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui X, Liu R, Duan L, Cao D, Zhang Q, Zhang A. CAR-T therapy: Prospects in targeting cancer stem cells. J Cell Mol Med 2021;25:9891-904. [PMID: 34585512 DOI: 10.1111/jcmm.16939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ye P, Chi X, Cha JH, Luo S, Yang G, Yan X, Yang WH. Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. Cells 2021;10:3309. [PMID: 34943817 DOI: 10.3390/cells10123309] [Reference Citation Analysis]
3 Farrukh H, El-Sayes N, Mossman K. Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells. Int J Mol Sci 2021;22:4893. [PMID: 34063096 DOI: 10.3390/ijms22094893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]